Skip to main content
. 2021 Jan 25;73(4):631–641. doi: 10.1093/cid/ciab051

Table 2.

Prevalence of Nontyphoidal Salmonella at GEMS Sites Among Children With Moderate-to-Severe Diarrhea (Cases) and Controls

Basse, The Gambia Bamako, Mali Manhica, Mozambique Nyanza Province, Kenya Kolkata, India Mirzapur, Bangladesh Karachi (Bin Qasim Town), Pakistan
Prevalence of NTS Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
0–11 Months
 No. of participants 400 585 727 727 374 697 673 673 672 685 550 878 633 633
 No. of NTS (%) 5 (1.3) 12 (2.1) 0 0 4 (0.8) 1 (0.1) 34 (5.1) 29 (4.3) 1 (0.1) 10 (1.5) 27 (4.9) 14 (1.6) 15 (2.4) 24 (3.8)
  Typhimurium 0 0 0 0 0 0 22 (3.3) 9 (1.3) 0 2 (0.6) 1 (0.2) 0 1 (0.2) 1 (0.2)
  Enteritidis 0 0 0 0 1 (0.3) 0 2 (0.3) 2 (0.3) 0 0 0 0 0 0
  Paratyphi B Java 0 0 0 0 0 0 0 0 0 1 (0.5) 11 (2.0) 8 (0.9) 1 (0.2) 0
  Serogroup O:4 0 0 0 0 0 1 (0.1) 2 (0.3) 5 (0.7) 0 1 (0.5) 1 (0.2) 0 2 (0.3) 2 (0.3)
  Serogroup O:6,7 1 (0.3) 2 (0.3) 0 0 0 0 3 (0.4) 3 (0.4) 0 0 9 (1.6) 4 (0.5) 4 (0.6) 4 (0.6)
  Serogroup O:8 0 1 (0.2) 0 0 1 (0.3) 0 2 (0.3) 4 (0.6) 1 (0.1) 1 (0.5) 5 (0.9) 1 (0.1) 7 (1.1) 13 (2.1)
  Other serovars 4 (1.0) 9 (1.5) 0 0 2 (0.5) 0 3 (0.4) 6 (0.9) 0 5 (0.7) 0 1 (0.1) 0 4 (0.6)
12–23 Months
 No. of participants 455 639 682 695 195 391 410 621 588 598 476 761 399 676
 No. of NTS (%) 6 (1.3) 8 (1.3) 1 (0.1) 0 1 (0.5) 0 24 (5.9) 21 (3.4) 1 (0.2) 2 (0.3) 7 (1.5) 9 (1.2) 14 (3.5) 19 (2.8)
  Typhimurium 0 0 0 0 0 0 15 (3.7) 6 (1.0) 0 0 2 (0.4) 1 (0.1) 1 (0.3) 3 (0.4)
  Enteritidis 0 0 0 0 0 0 4 (1.0) 2 (0.3) 0 0 2 (0.4) 0 1 (0.3) 1 (0.1)
  Paratyphi B Java 0 0 0 0 0 0 0 0 0 0 3 (0.6) 2 (0.3) 0 0
  Serogroup O:4 1 (0.2) 0 1 (0.1) 0 1 (0.5) 0 1 (0.2) 3 (0.5) 0 0 0 1 (0.1) 2 (0.5) 2 (0.3)
  Serogroup O:6,7 2 (0.4) 4 (0.6) 0 0 0 0 0 2 (0.3) 1 (0.2) 1 (0.2) 0 1 (0.1) 0 4 (0.6)
  Serogroup O:8 1 (0.2) 1 (0.2) 0 0 0 0 3 (0.7) 4 (0.6) 0 1 (0.2) 0 4 (0.5) 4 (1.0) 7 (1.0)
  Other serovars 2 (0.4) 3 (0.5) 0 0 0 0 1 (0.2) 4 (0.6) 0 0 0 0 6 (1.5) 2 (0.3)
24–59 Months
 No. of participants 174 345 624 642 112 208 393 589 308 731 368 826 226 529
 No. of NTS (%) 4 (2.3) 0 1 (0.2) 0 0 0 20 (5.1) 11 (1.9) 1 (1.0) 2 (0.3) 7 (2.2) 6 (0.7) 10 (5.8) 10 (2.3)
  Typhimurium 0 0 0 0 0 0 17 (4.3) 5 (0.8) 0 0 0 0 0 1 (0.2)
  Enteritidis 0 0 0 0 0 0 1 (0.3) 1 (0.2) 0 0 1 (0.3) 0 0 0
  Paratyphi B Java 0 0 0 0 0 0 0 0 0 0 2 (0.5) 2 (0.2) 0 0
  Serogroup O:4 0 0 1 (0.2) 0 0 0 1 (0.3) 0 0 0 0 0 1 (0.4) 3 (0.6)
  Serogroup O:6,7 3 (1.7) 0 0 0 0 0 1 (0.3) 0 1 (0.3) 2 (0.3) 2 (0.5) 2 (0.2) 2 (0.9) 1 (0.2)
  Serogroup O:8 0 0 0 0 0 0 0 2 (0.3) 0 0 0 0 3 (1.3) 1 (0.2)
  Other serovars 1 (0.6) 0 0 0 0 0 0 3 (0.5) 0 (0.6) 0 2 (0.8) 2 (0.2) 4 (3.1) 4 (1.1)
Total participants (all ages) 1029 1569 2033 2064 681 1296 1476 1883 1568 2014 1394 2465 1258 1838
Total no. of NTS (all ages) (%) 15 (1.5) 20 (1.3) 2 (0.1) 0 5 (0.9) 1 (0.1) 78 (5.3) 61 (3.2) 3 (0.2) 14 (0.7) 41 (2.9) 29 (1.2) 39 (3.1) 53 (2.9)

Abbreviations: GEMS, Global Enteric Multicenter Study; NTS, nontyphoidal Salmonella.